ArticleScientific reports2026
MCI detection from handwritten drawing test using residual vision transformer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mild Cognitive Impairment (MCI) is a clinical condition characterized by noticeable cognitive decline that is greater than expected for an individual’s age, yet not severe enough to interfere significantly with daily life. Early detection of MCI is critical, as it offers the opportunity to intervene before progression to more severe neurodegenerative diseases such as Alzheimer’s. While traditional diagnostic methods such as the Clock Drawing Test, Trail Making Test, and Cube Copying Test are widely used by clinicians, their manual assessment process can be subjective and time-consuming. This research addresses the automation of MCI detection using deep learning techniques applied to these neuro-psychological drawing tasks. A hybrid deep learning architecture—ResViT, which integrates ResNet50 for local feature extraction and a Vision Transformer (ViT) for capturing global context within the drawings, is being proposed. The ResViT architecture showed improved generalization and robustness across test cases, achieving a classification accuracy of 74.09% and an F1 score of 0.6716. Our results demonstrate that integrating Vision Transformer and ResNet architectures into a unified hybrid model enhances performance in cognitive disorder classification tasks, offering more accurate and measurable outcomes for early dementia detection through neuropsychological screening tools.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.